The MTP sector in Australia has some excellent examples of collaboration and commercialisation, but there is still a way to go for Australia to be the Asia-Pacific hub that it has the potential to be in the global market.
These examples are highlighted in our Sector Competitiveness Plan, which has identified guidelines and ways to establish Australia as a prominent environment for MTP sector development. MTPConnect's vision for Australia is to achieve greater commercialisation success, creating more products that reach proof-of-concept and early-stage commercialisation, increasing the number of medium-sized to large companies with late-stage product successes; and maximising the value of any IP-monetisation events along the way. MTPConnect facilitates collaboration, competitiveness, connectivity, and access by creating greater awareness and sharing of resources. It works closely with government and the sector in developing guidelines for allocating R&D grants and funding; and brings together pharmaceutical, biotech and medtech companies, research institutions and universities to achieve greater commercialisation success.
The Government's National Collaborative Research Infrastructure Strategy drives research excellence and collaboration between 35,000 researchers, government and industry representatives to deliver practical outcomes through the use of infrastructure such as assets, facilities and services to drive leading-edge innovation in Australia.
|Australian Animal Health Laboratory|| |
A high-containment facility designed to allow scientific research into the most dangerous infectious agents in the world.
|Australian Microscopy and Microanalysis Research Facility|| |
A national grid of equipment, instrumentation and expertise in microscopy and microanalysis for widely used and cutting edge techniques, including optical, electron and X-ray techniques.
|Australian National Fabrication Facility (ANFF)||Provides quick and easy access to facilities, professional services or academic collaborators, for the fabrication of prototype biomedical devices such as point-of-care diagnostics, biomaterials and 3D printing.|
|Australian Nuclear Science and Technology Organisation (ANSTO)|| |
Nuclear science and engineering facilities available to the research community and industry through peer-reviewed, collaborative and commercial arrangements. ANSTO can also provide assistance in the form of experiment design, sample preparation, use of the facilities and in analysing of data, comprehensive analytical and reactor-based services.
|Australian Phenomics Network (APN)||Provides tools and animal models to support the large-scale systematic study of gene function, such as curation and sharing of scientific data and providing open access storage through biobanking.|
|Bioplatforms Australia||Builds on the research capabilities and expertise in the specialist fields of genomics, proteomics, metabolomics and bioinformatics, with state-of-the-art infrastructure available to researchers from both academia and industry.|
|National Computational Infrastructure||Facility for digital experiments and modelling available to Australian researchers.|
|National Imaging Facility (NIF)||An Australia-wide collaborative network of imaging infrastructure that provides world-class imaging technologies and highly specialised expertise to research communities and industries, including project design consultation, data analysis and management, and technology advice for SMEs.|
|Pawsey Supercomputing Centre||A high-performance computing system capable of performing over 1 petaflop - over 1 quadrillion operations - every second, to support Australian computational research.|
|Population Health Research Network|| |
An organisation established to build a nationwide data linkage infrastructure capable of securely and safely managing health information from around Australia.
|Therapeutics Innovation Australia (TIA)||Supports the development and manufacture of small molecules, proteins and cell therapies, and provides quality documents and services including preclinical testing, molecular pathology and biostatistics.|
|CSIRO||CSIRO's Biomedical Materials Translational Facility (BMTF) helps medtech companies turn new discoveries into market ready products. It contains much of the equipment needed to develop a product though scale-up, prototyping, pre-clinical testing and industry evaluation.|